Additionally, prostate cancer stands as the most prevalent cancer diagnosis among men, with the identification of prostate-specific antigen (PSA) serving as a biomarker for early detection, emphasizing the clinical significance of recognizing molecular markers like TMEM16A in cancer diagnosis. This evidence concerns the gene KLK3 and cancer.